Dr Daniela Weiskopf | Instructor, Division of Vaccine Discovery
La Jolla Institute for Allergy and Immunology

Dr Daniela Weiskopf, Instructor, Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology

Dr. Weiskopf received her PhD in 2009 from the Innsbruck Medical University, Austria where she performed research analyzing post-translational modifications of viral derived epitopes as well as the influence of aging on modulation of the T cell immune response. Dr. Weiskopf joined Dr. Sette’s lab as a post-doctoral research fellow in 2009 and applied her knowledge of human T cell immune responses to human pathogens to understand the role of T cells in the context of infection with dengue virus.
Dr. Weiskopf has eleven years of experience in studying T cell immunity and six years specifically dedicated to the study of DENV-specific T cell responses. Over the last several years, she established and published a model of human DENV disease using HLA transgenic mouse strains.  Additionally, Dr. Weiskopf has led efforts to characterize human DENV-specific CD8+ and CD4+ T cell responses in both, samples from areas with endemic dengue infection and following vaccination. Dr. Weiskopf is the lead-author of multiple peer-reviewed publications relating to mapping and characterization of DENV specific T cell response. Dr. Weiskopf’s expertise is additionally evidenced by her selection as a speaker to present the results of the LJI DENV program at various national and international conferences.

back to speakers